Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 29, 2014 14:03 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Requests Pre-IND Feedback From FDA for Eltoprazine Phase IIb Parkinson's Disease Levodopa-Induced Dyskinesia Clinical Trial

SAN FRANCISCO and GENEVA, Sept. 29, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the development of diagnostics and therapeutics for...
September 25, 2014 16:00 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Shareholders Approve All Matters Voted Upon at Annual Shareholders Meeting

SAN FRANCISCO and GENEVA, Sept. 25, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the development of diagnostics and therapeutics for...
September 17, 2014 08:00 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Provides Program Update on Phase 2b Eltoprazine for Parkinson's Disease and Adult ADHD

SAN FRANCISCO and GENEVA, Sept. 17, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the development of diagnostics and therapeutics for...
September 12, 2014 10:30 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Completes Enrollment of 72 Patient LP-002 Clinical Study for Alzheimer's Blood Diagnostic LymPro Test(R)

SAN FRANCISCO and GENEVA, Sept. 12, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the development of diagnostic and therapeutic...
September 10, 2014 13:00 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus to Present Orphan Ocular Data at Targeting Ocular Disorders Conference 2014

SAN FRANCISCO and GENEVA, Sept. 10, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the development of diagnostic and therapeutic...
September 09, 2014 08:30 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Announces Positive MANF Ocular Toxicology Data

SAN FRANCISCO and GENEVA, Sept. 9, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the development of diagnostic and therapeutic...
September 04, 2014 09:00 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus to Present at Sachs Associates 14th Annual Biotech in Europe Forum for Global Partnering and Investment

SAN FRANCISCO and GENEVA, Sept. 4, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the development of diagnostic and therapeutic...
September 02, 2014 06:00 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Initiates CLIA Development of Alzheimer's Blood Diagnostic LymPro Test(R) at ICON Central Laboratories

SAN FRANCISCO and GENEVA, Sept. 2, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the development of diagnostic and therapeutic...
August 29, 2014 07:56 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Appoints Iain Ross to Board of Directors

SAN FRANCISCO and GENEVA, Aug. 29, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the development of diagnostic and therapeutic...
August 27, 2014 09:00 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Reports Second Quarter 2014 Financial Results, Announces Business Update Call

SAN FRANCISCO and GENEVA, Aug. 27, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the development of diagnostic and therapeutic...